Quantum BioPharma Ltd.
QNTM
$6.30
$0.060.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.56M | 9.19M | 9.07M | 8.92M | 12.87M |
| Depreciation & Amortization | 490.50K | 499.90K | 525.90K | 1.50M | 2.51M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.14M | 11.46M | 10.59M | 12.13M | 19.23M |
| Operating Income | -16.14M | -11.46M | -10.59M | -12.13M | -19.23M |
| Income Before Tax | -14.92M | -11.11M | -8.23M | -10.36M | -18.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.92 | -11.11 | -8.23 | -10.36 | -18.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 712.90K | 873.90K | 757.10K | 516.50K | 328.40K |
| Net Income | -14.20M | -10.24M | -7.47M | -9.85M | -17.90M |
| EBIT | -16.14M | -11.46M | -10.59M | -12.13M | -19.23M |
| EBITDA | -15.65M | -10.96M | -10.06M | -10.63M | -16.73M |
| EPS Basic | -14.85 | -14.45 | -12.03 | -16.28 | -29.77 |
| Normalized Basic EPS | -9.15 | -8.18 | -8.78 | -10.52 | -18.41 |
| EPS Diluted | -14.98 | -14.58 | -12.16 | -16.41 | -30.06 |
| Normalized Diluted EPS | -9.15 | -8.18 | -8.78 | -10.52 | -18.41 |
| Average Basic Shares Outstanding | 4.15M | 2.77M | 2.46M | 2.42M | 2.41M |
| Average Diluted Shares Outstanding | 4.15M | 2.77M | 2.46M | 2.42M | 2.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |